Abrogating the Induction of Type 2 Diabetes Mellitus Secondary to Statin Therapy

被引：0
|
作者：
Planchon, Sarah M. [1 ]
机构：
[1] Cleveland Clin, Mellen Ctr, Cleveland, OH 44195 USA
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2014年 / 28卷 / 05期
关键词：
RISK;
D O I：
10.1007/s10557-014-6551-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：393 / 394
页数：2
相关论文
共 50 条
  • [31] Pharmacologic therapy for type 2 diabetes mellitus
    DeFronzo, RA
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) : 73 - 74
  • [32] Incretin therapy for type 2 diabetes mellitus
    David C. Klonoff
    Advances in Therapy, 2010, 27 : 881 - 894
  • [33] Pharmaceutical therapy of diabetes mellitus type 2
    Laubner, K.
    Seufert, J.
    INTERNIST, 2007, 48 (03): : 297 - 308
  • [34] COMPARING CARDIOVASCULAR EVENT RATES OF STATIN PLUS FIBRATE COMBINATION THERAPY WITH STATIN MONOTHERAPY IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS
    Suh, H. S.
    Doctor, J. N.
    VALUE IN HEALTH, 2009, 12 (03) : A141 - A142
  • [35] Epigenetic Link Between Statin Therapy and Type 2 Diabetes
    Ochoa-Rosales, Carolina
    Portilla-Fernandez, Eliana
    Nano, Jana
    Wilson, Rory
    Lehne, Benjamin
    Mishra, Pashupati P.
    Gao, Xu
    Ghanbari, Mohsen
    Rueda-Ochoa, Oscar L.
    Juvinao-Quintero, Diana
    Loh, Marie
    Zhang, Weihua
    Kooner, Jaspal S.
    Grabe, Hans J.
    Felix, Stephan B.
    Schoettker, Ben
    Zhang, Yan
    Gieger, Christian
    Mueller-Nurasyid, Martina
    Heier, Margit
    Peters, Annette
    Lehtimaki, Terho
    Teumer, Alexander
    Brenner, Hermann
    Waldenberger, Melanie
    Ikram, M. Arfan
    van Meurs, Joyce B. J.
    Franco, Oscar H.
    Voortman, Trudy
    Chambers, John
    Stricker, Bruno H.
    Muka, Taulant
    DIABETES CARE, 2020, 43 (04) : 875 - 884
  • [36] Pattern of Statin use in patients with diabetes mellitus type 2 for primary and secondary prevention of cardiovascular disease in Saudi Arabia
    Ismail, Hussein M.
    Shora, Hassan A.
    Al-Nozha, Omar
    Yamany, Hussain A.
    Al-Nozha, Fareed
    Zaitone, Sawsan A.
    Alahmdi, Hussam
    Aljohani, Abdulsalam
    Almohammadi, Nawaf
    Abdallah, Ayat R.
    AFRICAN JOURNAL OF DIABETES MEDICINE, 2020, 28 (02):
  • [37] Cardiovascular risk in type 2 diabetes under statin therapy
    Numberger, Markus
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (02) : 107 - 108
  • [38] THE ASSOCIATION OF SOLUBLE ENDOGLIN AND ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS AND FAMILIAL HYPERCHOLESTEROLEMIA: IMPACT OF STATIN THERAPY
    Lasticova, M.
    Visek, J.
    Blaha, V.
    Blaha, M.
    Liptak, V.
    Nachtigal, P.
    ATHEROSCLEROSIS, 2022, 355 : E86 - E86
  • [39] Rosiglitazone reduces novel biomarkers of cardiovascular disease in subjects with type 2 diabetes mellitus already on statin therapy
    Brunzell, JD
    Marcovina, SM
    Yu, D
    Cobitz, AR
    Gould, EM
    Chen, H
    Porter, LE
    EUROPEAN HEART JOURNAL, 2004, 25 : 385 - 385
  • [40] Apolipoprotein E genotypes affect the response to statin therapy in Singaporean Chinese patients with Type 2 Diabetes mellitus
    Koh, AFY
    Tavintharan, S
    Goh, T
    Lim, VCC
    Xu, XH
    Lim, SC
    Sum, CF
    DIABETES, 2005, 54 : A235 - A235
12345